1-4 of 4
Derralynn Hughes
Close
Sort by
Journal Articles

Bortezomib Consolidation Following Upfront ASCT for Multiple Myeloma Deepens Disease Response and MRD-Negative Rate without Compromising Response to Subsequent Bortezomib Salvage: Results of a Phase II Study

Oliver C Cohen, MBBS MRCP, Neil Rabin, Nicholas Counsell, Roger G Owen, MD PhD, Bilyana Popova, Oliver Schofield, Janet Lyons-Lewis, Andy Rawstron, Christopher Spence, Ruth Mary de Tute, PhD FRCPath, Derralynn Hughes, MRCP, MRCPath, DPhil, MA, Sally Moore, BSc, FRPATH, FRCP, MBBS, Paul Smith, PhD, Kwee L Yong
Journal: Blood
Blood (2016) 128 (22): 4508.
https://doi.org/10.1182/blood.V128.22.4508.4508
Published: 2016
Journal Articles

Miglustat Therapy in Type 1 Gaucher Disease: Long-Term Treatment Experience From a Multicenter, Retrospective Cohort Study,

David J. Kuter, MD, DPhil, Atul Mehta, MD, Carla Hollak, MD, PhD, Pilar Giraldo, MD, PhD, Derralynn Hughes, MRCP, MRCPath, DPhil, MA, Nadia Belmatoug, MD, Monika Brand, Audrey Muller, Berthold Schaaf, Ruben Giorgino, Ari Zimran, MD
Journal: Blood
Blood (2011) 118 (21): 3207.
https://doi.org/10.1182/blood.V118.21.3207.3207
Published: 2011
Journal Articles

Variation of Serum Lipid Profile during Enzyme Replacement Therapy, in Patients with Type 1 Gauchers Disease.

Argiris Symeonidis, Derralynn Hughes, Linda Richfield, Atul Mehta
Journal: Blood
Blood (2006) 108 (11): 3849.
https://doi.org/10.1182/blood.V108.11.3849.3849
Published: 2006
Journal Articles

Retrospective Analysis of Causes and Consequence of Delay in Diagnosis of Multiple Myeloma.

Chitranga C. Kariyawasan, Derralynn Hughes, Atul B. Mehta
Journal: Blood
Blood (2006) 108 (11): 5056.
https://doi.org/10.1182/blood.V108.11.5056.5056
Published: 2006